Nuzenio

Ovid Therapeutics

Ovid Therapeutics news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 9 latest news signals 9 publisher sources 100/100 entity strength

Latest news

"Biotech in the Balance" - Dr. Jeremy Levin, author and Chair of Ovid Therapeutics - marketscale.commarketscale.com · Sat, 08 Aug 2026 19:45:29 GMT Ovid Therapeutics Inc (OVID) News, Articles, Events & Latest Updates - StocktwitsStocktwits · Sat, 08 Aug 2026 10:32:12 GMT Ovid Therapeutics Inc (NASDAQ: OVID) Share Price, OVID Stock News, OVID Share Price & Updates - KalkineKalkine · Fri, 07 Aug 2026 20:19:00 GMT Ovid Therapeutics Inc. (OVID) stock price, news, quote and history - Yahoo Finance UKYahoo Finance UK · Fri, 07 Aug 2026 16:38:12 GMT Outlook Therapeutics, Inc. (OTLK) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 14:00:04 GMT OVID Maintained by Oppenheimer -- Price Target Raised to $9.00 - GuruFocusGuruFocus · Mon, 03 Aug 2026 17:37:30 GMT Oppenheimer Adjusts Ovid Therapeutics Price Target to $9 From $7, Maintains Outperform Rating - marketscreener.commarketscreener.com · Mon, 03 Aug 2026 13:15:32 GMT OVID THERAPEUTICS INC. : OPPENHEIMER RAISES TARGET PRICE TO $9 FROM $7 - BitgetBitget · Mon, 03 Aug 2026 07:00:00 GMT

Timeline

Sat, 08 Aug 2026 19:45:29 GMT"Biotech in the Balance" - Dr. Jeremy Levin, author and Chair of Ovid Therapeutics - marketscale.com

Sat, 08 Aug 2026 10:32:12 GMTOvid Therapeutics Inc (OVID) News, Articles, Events & Latest Updates - Stocktwits

Fri, 07 Aug 2026 20:19:00 GMTOvid Therapeutics Inc (NASDAQ: OVID) Share Price, OVID Stock News, OVID Share Price & Updates - Kalkine

Fri, 07 Aug 2026 16:38:12 GMTOvid Therapeutics Inc. (OVID) stock price, news, quote and history - Yahoo Finance UK

Thu, 06 Aug 2026 14:00:04 GMTOutlook Therapeutics, Inc. (OTLK) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release - Yahoo Finance

Mon, 03 Aug 2026 17:37:30 GMTOVID Maintained by Oppenheimer -- Price Target Raised to $9.00 - GuruFocus

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.

Connected entities

OVID7 live mentions Ovid Therapeutics Inc6 live mentions Inc4 live mentions Yahoo Finance UK3 live mentions Biotech2 live mentions Balance2 live mentions Jeremy Levin2 live mentions Chair2 live mentions Articles2 live mentions Events2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Ovid Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

9 distinct publisher/source names are currently connected to this entity page.